These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20336059)

  • 1. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.
    Maayan L; Vakhrusheva J; Correll CU
    Neuropsychopharmacology; 2010 Jun; 35(7):1520-30. PubMed ID: 20336059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
    Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H
    Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
    J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis.
    Wang Y; Wang D; Cheng J; Fang X; Chen Y; Yu L; Ren J; Tian Y; Zhang C
    J Psychopharmacol; 2021 Sep; 35(9):1111-1119. PubMed ID: 34311625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Praharaj SK; Jana AK; Goyal N; Sinha VK
    Br J Clin Pharmacol; 2011 Mar; 71(3):377-82. PubMed ID: 21284696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.
    Caemmerer J; Correll CU; Maayan L
    Schizophr Res; 2012 Sep; 140(1-3):159-68. PubMed ID: 22763424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
    Björkhem-Bergman L; Asplund AB; Lindh JD
    J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interventions for the treatment of obesity in children and adolescents.
    Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of metformin to limit weight-gain with atypical antipsychotics.
    Lee YJ; Jeong JH
    J Clin Pharm Ther; 2011 Oct; 36(5):537-45. PubMed ID: 21418264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Topiramate for atypical antipsychotic-induced body weight gain and metabolic adversities: a systematic review and meta-analysis].
    Liang H; Li H; Hu Y; Li S; Lü L; Song X
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):216-23. PubMed ID: 26879726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of antipsychotic-related weight gain.
    Maayan L; Correll CU
    Expert Rev Neurother; 2010 Jul; 10(7):1175-200. PubMed ID: 20586697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
    Siskind D; Hahn M; Correll CU; Fink-Jensen A; Russell AW; Bak N; Broberg BV; Larsen J; Ishøy PL; Vilsbøll T; Knop FK; Kisely S; Ebdrup BH
    Diabetes Obes Metab; 2019 Feb; 21(2):293-302. PubMed ID: 30187620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
    Werneke U; Taylor D; Sanders TA
    Int Clin Psychopharmacol; 2002 Jul; 17(4):145-60. PubMed ID: 12131598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis.
    Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S
    PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.